Gangwal Healthcare

India

CPhI India 2024

Booth #8.Q10

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : DiCOM-DC® SR300

Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

Dosage Form : Capsule, Tablet

Grade : Oral

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

Dosage Form : Capsule, Tablet

Category : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

Brand : DICOM-DC® SR300

Applications : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

Looking for Vilanterol Trifenatate? Find Controlled & Modified Release used in Vilanterol Trifenatate to address drug delivery challenges on PharmaCompass.

Vilanterol Trifenatate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers

8 USDMF

4 EU WC

1 KDMF

9 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

INTERMEDIATES

10 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

41 FDF Dossiers

6 FDA Orange Book

30 Europe

5 South Africa

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH

POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH

RELATED EXCIPIENT COMPANIES

2 Faran Shimi Pharmaceutical

4 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 DFE Pharma

14 Kerry

7 Microlex e.U

2 Pluviaendo

1 Prachin Chemical

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Sigachi Industries

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

25 Fillers, Diluents & Binders

8 Lubricants & Glidants

8 Direct Compression

5 Co-Processed Excipients

4 Granulation

1 Controlled & Modified Release

1 Emulsifying Agents

1 Thickeners and Stabilizers

1 Parenteral

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

42 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

30 Finished Drug Prices

10 Annual Reports

MARKET PLACE

2 APIs

PATENTS & EXCLUSIVITIES

110 US Patents

4 US Exclusivities

REF. STANDARDS & IMPURITIES

10 Others

Filters

Vilanterol Trifenatate

01

Gangwal Healthcare